INTRODUCTION
Paraneoplastic syndromes (PNS) are disorders caused by remote effects of tumors in various organs without direct invasion or metastasis. Cancer-associated retinopathy (CAR) is a PNS causing retinal dysfunction leading to ocular symptoms . CAR is believed to be caused by autoantibodies against various retinal antigens ( recoverin , neurofilaments, or other proteins). Among these, only anti-recoverin antibodies can be detected by a commercially available test, so a diagnosis of CAR cannot be ruled out even if the anti-recoverin antibody is not detected.
On the other hand, occurrence of carcinoma in mediastinal or hilar lymph nodes with no known primary site is uncommon. In some of these cases, uncertainty persists as to whether the lymph node cancer is primary or metastatic. We report a case of small cell carcinoma in mediastinal lymph nodes with no known primary site that caused CAR. To the best of our knowledge, this is the first report of a patient with both CAR and metastatic thoracic lymph nodes with no known primary site , al-though a primary lung cancer was detected many months later. The pneumonia was treated with antibiotics, and the abnormal shadow in the right middle lobe disappeared. The patient's height was 156.5 cm, and her weight was 51.5 kg. The blood pressure was 138/70 mmHg, with a pulse rate of 88 beats/ min. Heart and breath sounds were normal. No superficial lymphadenopathy was evident. The peripheral blood count was normal. Serologic tests for hepatitis C antibody were positive. Blood chemistry results were within normal limits except for increased triglyceride. The CEA concentration was 8.3 ng/ ml. Pulmonary function values were normal in spite of severe emphysema demonstrated by chest CT. Results of arterial blood gas analysis were PaCO2, 43.9 mmHg; Pa02, 71.1 mmHg; and pH, 7.385. A chest roentgenogram revealed slight prominence of the right upper mediastinum ( Figure 1 ). Chest CT showed a mass in the upper mediastinum extending anterolaterally to compress the right brachiocephalic vein ( Figure 2 ). The pneumonic shadow in the right middle lobe that had been seen in the previous CT had disappeared, but no parenchymal mass could be detected. Severe emphysema was demonstrated bilaterally in the upper lobes and the basal areas of the lower lobes. MRI of the brain revealed no metastatic lesion. No abnormality in the tracheal wall or in any visible SCLC line from a patient with CAR, 6 and anti-recoverin antibody has been detected in low titers even in sera from some SCLC patients without CAR.7 These findings represent the basis for a persuasive hypothesis concerning the pathogenesis of CAR. SCLC cells, which have a neuroendocrine origin, ectopically produce recoverin or other proteins . Autoantibodies against these antigens cross-react with native recoverin (or other proteins) in retinal tissues, resulting in degeneration of the retina and visual disturbance . However, not every CAR occurs in SCLC patients . We collected 57 cases of CAR that had been reported until recently including our case ( Table 1) .
CASE REPORT
The percentage of SCLC in all CAR was 75.4%. It is diffi-cult to explain why other cancers besides small cell cancer cause CAR.
Controversy persists concerning metastatic mediastinal and/or hilar lymphadenopathy of unknown origin. [8] [9] [10] [11] [12] [13] [14] [15] Some authors maintain that these cancers in thoracic lymph nodes are primary, not metastatic. Riquet 15 microscopically demonstrated that nonneoplastic glandular tissue can exist in lymph nodes, representing a potential origin for carcinoma . Most cases of carcinoma found solely in nodes have been reported from Japan, [8] [9] [10] 12, 14 which might reflect relatively aggressive treatment for presumed lung cancer with evidence of metastasis to mediastinal lymph nodes . Because resection is performed A B Figure 6 . A. A minute area with altered opacity (arrow) can be recognized retrospectively in the right lower lobe by computed tomography (CT) obtained just before the first operation. B. A primary tumor at the same site is evident by CT performed 15 months later. Of 97 patients with resected thoracic lymph node can-cer of unknown primary site, 10 (10.3%) attained cancerfree survival more than three years postoperatively. And six of them (6.2%) had survived more than five years without recurrence with one exceptional case, in which a primary site appeared 65 months postoperatively.14 We therefore believe that resection of these lesions is indicated.
CONCLUSION
In a patient with SCLC associated with CAR, metastatic tumor in mediastinal lymph nodes had been resected 15 months before any primary cancer appeared in the lung.
CAR also antedated detection of the lung tumor. Although antibodies to the CAR antigen ( one of several CAR-related antigens) could not be detected, the clinical courses of sudden and ongoing visual deterioration as well as ophthalmologic findings were diagnostic. We anticipate that future availability of tests for antibodies against other CAR-related antigens will facilitate early diagnosis.
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